Enzymatica
3,03
SEK
0 %
Mindre end 1K følgere
ENZY
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Ownership
Investor consensus
Enzymatica is a life science company that develops and sells medical devices for infection-related diseases. The products are based on barrier technology, which includes marine enzymes. The company's first product is ColdZyme® Mouth Spray which can prevent colds as well as shorten the illness period. The product has been launched on several markets and the strategy is to expand to more markets via partners. The company is headquartered in Lund.
Læs mereMarkedsværdi
735,49 mio. SEK
Aktieomsætning
184,47 t SEK
Omsætning
45,58 mio.
EBIT %
-114,22 %
P/E
-
Udbytteafkast, %
-
Finanskalender
17.7
2025
Delårsrapport Q2'25
30.10
2025
Delårsrapport Q3'25
18.2
2026
Årsrapport '25
Alle
Selskabsmeddelelser
Eksterne analyser
ViserAlle indholdstyper
Bulletin from the annual general meeting of Enzymatica AB (publ) on May 7, 2025
Enzymatica AB: BioStock: Enzymatica gears up for global expansion after a strong first quarter
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools